January 2026
DMT
What January 2026's 11 new studies found, synthesized from the papers below. All DMT research →
The synthesis
Synthesized from 3 studies in the library · AI-generated, grounded in the abstracts below
Found by searching the library for DMT, dimethyltryptamine, 5-MeO-DMT, then ranked by relevance.
Research on DMT published in January 2026 shows that a single dose can reverse anhedonia and cognitive deficits in a mouse model of depression, and that DMT has neuroprotective effects in a rat model of spinal injury. A micro-phenomenological study in humans found that DMT-induced immersion and perceived presences follow a structured, hierarchical developmental pattern. However, the evidence is limited to animal models and a single human study with a small sample, and no clinical trials in humans were reported.
Evidence by study
Direction is which way each study's own result points, not our rating of the study.
What the directions mean
- Supports:
- the study found the intervention worked, or its hypothesis held.
- Opposes:
- it found the opposite, no benefit or a harm.
- No effect:
- no significant difference either way.
- Mixed:
- effects in both directions within the same study.
- Unclear:
- the abstract does not report a direction.
| Study | Design | Sample size | Direction | Finding |
|---|---|---|---|---|
| Single-dose DMT reverses anhedonia and cognitive deficits via restoration of neurogenesis in a stress-induced depression model. 2026 | preclinical animal study | Supports | A single dose of DMT reversed anhedonia and cognitive deficits in stressed mice, outperforming chronic fluoxetine, and increased adult-born granule cell integration. | |
| Combined Neuroprotective Effects of N,N‐Dimethyltryptamine and Ventral Root Reimplantation Following Spinal Root Avulsion in Rats 2026 | preclinical animal study | Supports | DMT at 1 mg/kg combined with surgical reimplantation enhanced motor neuron survival, reduced glial reactivity, and preserved synaptic boutons after spinal root avulsion. | |
| Micro-phenomenology of immersion and perceived presences under DMT. 2026 | qualitative micro-phenomenological study | 23 | Supports | Micro-phenomenological analysis revealed that DMT-induced immersion follows a structured continuum, with bodily effects preceding visual/auditory ones, and perceived presences emerging only after multisensory integration. |
A single dose of DMT reversed anhedonia and cognitive deficits in stressed mice, outperforming chronic fluoxetine, and increased adult-born granule cell integration.
preclinical animal study
DMT at 1 mg/kg combined with surgical reimplantation enhanced motor neuron survival, reduced glial reactivity, and preserved synaptic boutons after spinal root avulsion.
preclinical animal study
Micro-phenomenological analysis revealed that DMT-induced immersion follows a structured continuum, with bodily effects preceding visual/auditory ones, and perceived presences emerging only after multisensory integration.
qualitative micro-phenomenological study Sample size: 23
Points of agreement
- DMT shows potential therapeutic effects in preclinical models (antidepressant-like, neuroprotective).
- DMT induces structured, immersive experiences with perceived presences in humans.
Conflicts
- No direct conflicts; studies address different aspects (animal behavior, neuroprotection, human phenomenology).
Gaps
- No human clinical trials on DMT efficacy or safety were reported.
- Durability of effects and long-term outcomes are unstudied.
- Role of the psychedelic experience vs. direct pharmacological action remains unclear.
- Small sample sizes and lack of blinding in the human study.
- No studies on DMT in clinical populations (e.g., depression, PTSD) in this period.